Thrivent Financial for Lutherans
SNY icon

Thrivent Financial for Lutherans’s Sanofi SNY Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Sell
17,899
-1,030
-5% -$46K ﹤0.01% 2129
2026
Q1 		$905K Sell
18,929
-2,109,788
-99% -$98.4M ﹤0.01% 1940
2025
Q4 		$103M Sell
2,128,717
-71,390
-3% -$3.54M 0.18% 110
2025
Q3 		$104M Buy
2,200,107
+2,178,647
+10,152% +$105M 0.2% 106
2025
Q2 		$1.03M Buy
21,460
+11,412
+114% +$583K ﹤0.01% 1766
2025
Q1 		$512K Sell
10,048
-1,933,713
-99% -$105M ﹤0.01% 2060
2024
Q4 		$93.8M Buy
1,943,761
+514,542
+36% +$26.2M 0.18% 138
2024
Q3 		$82.4M Buy
1,429,219
+1,424,289
+28,890% +$76.9M 0.16% 186
2024
Q2 		$239K Sell
4,930
-21
-0.4% -$1.01K ﹤0.01% 2448
2024
Q1 		$241K Sell
4,951
-690
-12% -$33.7K ﹤0.01% 2427
2023
Q4 		$281K Sell
5,641
-183
-3% -$8.95K ﹤0.01% 2373
2023
Q3 		$309K Buy
5,824
+216
+4% +$11.5K ﹤0.01% 2299
2023
Q2 		$297K Sell
5,608
-11,939
-68% -$642K ﹤0.01% 2331
2023
Q1 		$953K Buy
17,547
+7,464
+74% +$363K ﹤0.01% 1815
2022
Q4 		$488K Sell
10,083
-300
-3% -$13.2K ﹤0.01% 2129
2022
Q3 		$395K Buy
+10,383
New +$463K ﹤0.01% 2157
2017
Q4 		– Sell
-103
Closed -$5K – 2261
2017
Q3 		$5K Buy
+103
New +$4.98K ﹤0.01% 2213
2014
Q1 		– Sell
-1,252,920
Closed -$67.2M – 1581
2013
Q4 		$67.2M Sell
1,252,920
-524,900
-30% -$27.1M 0.41% 58
2013
Q3 		$90M Buy
1,777,820
+312,800
+21% +$15.9M 0.57% 48
2013
Q2 		$75.5M Buy
+1,465,020
New +$78.1M 0.49% 52

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Thrivent Financial for Lutherans's SNY Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Sanofi (SNY) stake by 5.4% in Q2 2026, selling an estimated $46K and leaving 17,899 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Thrivent Financial for Lutherans first reported a position in SNY in Q2 2013 and has held it in 20 quarters since. The position peaked at $104M in Q3 2025. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Thrivent Financial for Lutherans held 17,899 shares of Sanofi worth $766K as of Q2 2026.
  • Thrivent Financial for Lutherans sold 1,030 Sanofi shares in Q2 2026, an estimated $46K.
  • Sanofi made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2129 holding.
  • Thrivent Financial for Lutherans first reported a position in Sanofi in Q2 2013 and has held it in 20 quarters since.
  • Thrivent Financial for Lutherans's Sanofi position peaked at $104M in Q3 2025.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.